CrossRefPubMed 25 Danese PN, Pratt LA, Kolter R:

CrossRefPubMed 25. Danese PN, Pratt LA, Kolter R: Exopolysaccharide production is required for development of Escherichia coli K-12 biofilm architecture. J Bacteriol 2000,182(12):3593–3596.CrossRefPubMed 26. Wang X, Preston JF 3rd, Romeo T: The pga ABCD locus of Escherichia coli promotes the synthesis of a polysaccharide CFTRinh-172 datasheet adhesin required for biofilm formation. J Bacteriol 2004,186(9):2724–2734.CrossRefPubMed

27. Prigent-Combaret C, Prensier G, Le Thi TT, Vidal O, Lejeune P, Dorel C: Developmental pathway for biofilm formation in curli-producing Escherichia coli strains: role of flagella, curli and colanic acid. Environ Microbiol 2000,2(4):450–464.CrossRefPubMed 28. Solano C, Garcia B, Valle J, Berasain C, Ghigo J-M, Gamazo C, Lasa I: Genetic analysis of Salmonella enteritidis biofilm formation: critical role of cellulose. Mol Microbiol 2002,43(3):793–808.CrossRefPubMed 29.

Wai SN, Mizunoe Y, Takade A, Kawabata S-I, Yoshida S-I:Vibrio cholerae O1 strain TSI-4 produces the exopolysaccharide materials that determine colony morphology, stress resistance, and biofilm formation. Appl Environ Microbiol 1998,64(10):3648–3655.PubMed 30. Gotz F: Staphylococcus and BEZ235 price biofilms. Mol Microbiol 2002,43(6):1367–1378.CrossRefPubMed 31. Branda SS, Gonzalez-Pastor JE, Dervyn E, Ehrlich SD, Losick R, Kolter R: Genes involved in formation of structured multicellular communities by Bacillus subtilis. J Bacteriol 2004,186(12):3970–3979.CrossRefPubMed 32. Dyer JK, Bolton RW: Purification and chemical characterization of an exopolysaccharide isolated from Capnocytophaga https://www.selleckchem.com/products/Cyt387.html ochracea. Can J Microbiol 1985,31(1):1–5.CrossRefPubMed 33. Bolton RW, Dyer JK,

Reinhardt RA, Okano DK: Modulation of in vitro human lymphocyte responses by an exopolysaccharide from Capnocytophaga ochracea. J Dent Res 1983,62(12):1186–1189.CrossRefPubMed 34. Schwarzmann S, Boring JR III: Antiphagocytic effect of slime from a mucoid strain of Pseudomonas aeruginosa. Infect Immun 1971, 3:762–767.PubMed 35. Yasuda H, Ajiki Y, Aoyama J, Yokota T: Interaction Thiamet G between human polymorphonuclear leucocytes and bacteria released from in-vitro bacterial biofilm models. J Med Microbiol 1994,41(5):359–367.CrossRefPubMed 36. Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, DeLeo FR, Otto M: Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol 2004,6(3):269–275.CrossRefPubMed 37. Lopez-Torres AJ, Stout V: Role of colanic acid polysaccharide in serum resistance in vivo and in adherence. Curr Microbiol 1996,33(6):383–389.CrossRefPubMed 38. Yu H, Boucher J, Hibler N, Deretic V: Virulence properties of Pseudomonas aeruginosa lacking the extreme- stress sigma factor AlgU (sigmaE). Infect Immun 1996,64(7):2774–2781.PubMed 39.

Comments are closed.